Less Chemotherapy, Better Outcomes: Immunotherapy Advances Treatment for High-Risk Childhood Leukemia
Less Chemotherapy, Better Outcomes: Immunotherapy Advances Treatment for High-Risk Childhood Leukemia (Vienna, 17.09.2026) – Treating childhood leukemia often requires intensive chemotherapy, which can severely weaken the immune system and increase the risk of life-threatening infections. An international clinical study involving the Clinical Trials Unit led by Andishe Attarbaschi at St. Anna Children’s Cancer Research Institute (St. […]